The effect of a selective urate reabsorption inhibitor dotinurad on uric acid and renal function in patients with hyperuricemia and hypertension.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Therapeutic approaches to hypertension and its comorbidities Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by